2018
DOI: 10.1111/codi.14417
|View full text |Cite
|
Sign up to set email alerts
|

Advancement flap procedure in Crohn and non‐Crohn perineal fistulas: a simple surgical approach

Abstract: Rectal flap advancement is a satisfactory option for the therapeutic management of anal fistula, including CD populations. Fistula drainage is needed before performing this surgical technique.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
4
4

Relationship

1
7

Authors

Journals

citations
Cited by 15 publications
(8 citation statements)
references
References 18 publications
0
8
0
Order By: Relevance
“…Lowering the tract is an important strategy in managing high/complex fistulas. Therefore, effective fistula drainage, which may include several interventions, is needed to avoid SST failure, in particular rectal flap advancement [10]. Furthermore, luminal disease was controlled and no patient had active proctitis.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Lowering the tract is an important strategy in managing high/complex fistulas. Therefore, effective fistula drainage, which may include several interventions, is needed to avoid SST failure, in particular rectal flap advancement [10]. Furthermore, luminal disease was controlled and no patient had active proctitis.…”
Section: Discussionmentioning
confidence: 99%
“…Failure of the procedure (SST or fistulotomy or seton removal) was defined as the occurrence of at least one of the following items: abscess recurrence, purulent discharge from the tract, visible external opening or drainage surgery [10].…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Obesity was identified as an independent negative predictor of outcome (Table 1) 37,38 but was discredited by three others. 33,36,39 In our opinion, TAFR can be considerably more challenging in obese patients, so there may definitely be a rationale behind this factor. Unfortunately, due to conflicting evidence as well as the difficulty of intervening, this factor does not seem to be a worthwhile modifiable factor.…”
Section: Patient-related Factorsmentioning
confidence: 92%
“…All these patients were on anti‐tumour necrosis factor alpha therapy. There is now growing evidence that in patients with Crohn's fistulae, it is essential to combine surgery with biologic agents . When managing Crohn's fistulae, combining a surgical procedure, which prevents entry of bacteria to the fistula, with immunotherapy seems to be the logical approach.…”
mentioning
confidence: 99%